7th Jul 2011 14:52
For Immediate Release | 7 July 2011 |
SkyePharma PLC ("the Company")
The Company was informed on 7 July 2011 that as a result of transactions on 30 June 2011 by the SkyePharma PLC Share Purchase Plan (the "Plan") (an approved all employee share purchase plan) the Trustees of the Plan purchased an additional 1,162 Ordinary Shares of the Company at a price of £0.4725 per share.
As a result of these transactions, Peter Grant, a Director of the Company, has the following additional interests as a result of his personal participation in the Plan:-
Partnership Shares purchased on 30 June 2011 at £0.4725 per share | Matching Shares awarded on 30 June 2011 at £0.4725 per share |
|
264 | 264 |
In accordance with the rules of the Plan, Mr Grant has been awarded Matching Shares on the basis of one Matching Share (Ordinary Share) for each Partnership Share (Ordinary Share).
The beneficial ownership of the Matching Shares will pass to Mr Grant in three years' time subject to continued employment and the retention of the underlying Partnership Shares.
The following shares have been released from the Plan following expiry of the third anniversary and beneficial ownership of the Matching shares has now passed to Mr Grant, who continues to hold all the shares released:
Partnership Shares Released 2 July 2011 | Matching Shares Released 2 July 2011 | Total number of Partnership and Matching Shares held on 7 July 2011 |
21 | 21 | 14,135 |
The execution of the transaction noted above did not involve any of the Company's Directors or any persons discharging managerial responsibility.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Related Shares:
SKP.L